Real time and in vivo pharmaceutical and environmental studies with SpiderMass instrument

•SpiderMass allows to perform in vivo Real time ADME/DPMK pharmaceutical product studies.•Metabolites/lipids from Knock-Down Proprotein Convertase Macrophages can be in petri dish directly identified.•Pollutants (car Soots) car be detected in real time on skins with SpiderMass.•Personalize dermatolo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of biotechnology 2018-09, Vol.281, p.61-66
Hauptverfasser: Fatou, B., Saudemont, P., Duhamel, M., Ziskind, M., Focsa, C., Salzet, M., Fournier, I.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•SpiderMass allows to perform in vivo Real time ADME/DPMK pharmaceutical product studies.•Metabolites/lipids from Knock-Down Proprotein Convertase Macrophages can be in petri dish directly identified.•Pollutants (car Soots) car be detected in real time on skins with SpiderMass.•Personalize dermatology can be retrieved in real time by SpiderMass. Remote Infrared Matrix Assisted Laser Desorption Ionization (Remote IR MALDI) system (SpiderMass) with endogenous water as matrix allows to perform real-time DMPK in vivo. In this work, SpiderMass was used to analyze the impact on metabolite production or release of invalidated pro-protein PC1/3 macrophages by Short RNA (shRNA) versus scramble shRNA with Paclitaxel. Time course in vivo experiments were then performed on the inner and outer faces of patients’ forearms or comedo treated with Melascreen (Ducray) containing ascorbyl glucoside. Finally, the impact of car pollution (emitted soot) on skin was also investigated. Taken together, we demonstrate that the SpiderMass instrument opens the door to clinical, pharmaceutical and environmental domains for real-time, in vivo pharmacokinetic (Drug Metabolism and PharmacoKinetics, DMPK) analysis.
ISSN:0168-1656
1873-4863
DOI:10.1016/j.jbiotec.2018.06.339